Stockscreener 앱 받기
207.55
0.14%
-0.30
시간 외 거래:
205.01
-2.54
-1.22%
전일 마감가:
$207.85
열려 있는:
$207.85
하루 거래량:
1.31M
Relative Volume:
0.80
시가총액:
$34.64B
수익:
$16.63B
순이익/손실:
$1.39B
주가수익비율:
25.73
EPS:
8.0674
순현금흐름:
$2.12B
1주 성능:
+0.77%
1개월 성능:
+14.38%
6개월 성능:
-14.08%
1년 성능:
+27.49%
1일 변동 폭
$206.74
$212.36
1주일 범위
$201.16
$212.36
52주 변동 폭
$154.50
$247.04
아이큐비아 홀딩스 Stock (IQV) Company Profile
명칭
Iqvia Holdings Inc
전화
919-998-2000
주소
2400 ELLIS ROAD, DURHAM, NC
Compare IQV vs TMO, DHR, IDXX, NTRA, A
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IQV
Iqvia Holdings Inc
|
207.55 | 34.69B | 16.63B | 1.39B | 2.12B | 8.0674 |
TMO
Thermo Fisher Scientific Inc
|
528.51 | 195.86B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
200.16 | 140.88B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
564.21 | 44.46B | 4.45B | 1.10B | 1.06B | 13.59 |
NTRA
Natera Inc
|
272.89 | 38.66B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
134.04 | 37.93B | 7.23B | 1.41B | 1.09B | 4.979 |
아이큐비아 홀딩스 Stock (IQV) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-09 | 업그레이드 | TD Cowen | Hold → Buy |
| 2026-03-06 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2026-03-03 | 개시 | RBC Capital Mkts | Outperform |
| 2025-12-02 | 재개 | Morgan Stanley | Overweight |
| 2025-11-13 | 개시 | BMO Capital Markets | Outperform |
| 2025-11-03 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2025-10-29 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2025-10-09 | 업그레이드 | HSBC Securities | Hold → Buy |
| 2025-09-09 | 업그레이드 | Jefferies | Hold → Buy |
| 2025-04-25 | 다운그레이드 | HSBC Securities | Buy → Hold |
| 2025-04-10 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2025-02-03 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2024-12-20 | 개시 | Stephens | Overweight |
| 2024-10-14 | 개시 | Redburn Atlantic | Buy |
| 2024-09-04 | 개시 | RBC Capital Mkts | Outperform |
| 2024-07-24 | 다운그레이드 | Jefferies | Buy → Hold |
| 2024-06-06 | 개시 | Goldman | Buy |
| 2024-02-26 | 개시 | Leerink Partners | Outperform |
| 2024-02-15 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2024-02-13 | 개시 | BTIG Research | Buy |
| 2023-11-02 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2023-09-06 | 개시 | HSBC Securities | Buy |
| 2023-03-17 | 개시 | Truist | Buy |
| 2022-12-06 | 개시 | Cowen | Outperform |
| 2022-11-17 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-08-25 | 개시 | Credit Suisse | Outperform |
| 2022-07-15 | 개시 | SVB Leerink | Outperform |
| 2022-05-24 | 개시 | Guggenheim | Buy |
| 2022-04-29 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2022-04-25 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2021-08-05 | 재개 | Credit Suisse | Outperform |
| 2021-04-16 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2021-03-08 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | 개시 | Barclays | Overweight |
| 2020-07-07 | 개시 | Stephens | Equal-Weight |
| 2020-03-02 | 개시 | Deutsche Bank | Buy |
| 2020-01-08 | 개시 | Wells Fargo | Overweight |
| 2020-01-07 | 개시 | Citigroup | Buy |
| 2019-12-13 | 업그레이드 | CFRA | Sell → Hold |
| 2019-11-14 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2019-06-21 | 업그레이드 | Mizuho | Neutral → Buy |
| 2019-05-28 | 개시 | SVB Leerink | Outperform |
| 2019-01-18 | 업그레이드 | Jefferies | Hold → Buy |
| 2018-10-09 | 개시 | UBS | Buy |
| 2018-10-02 | 재확인 | Robert W. Baird | Outperform |
| 2018-07-25 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2018-07-25 | 재확인 | Stifel | Buy |
| 2018-07-03 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2018-04-13 | 업그레이드 | Goldman | Neutral → Buy |
| 2018-03-07 | 업그레이드 | SunTrust | Hold → Buy |
| 2018-01-19 | 개시 | Evercore ISI | Outperform |
모두보기
아이큐비아 홀딩스 주식(IQV)의 최신 뉴스
Mizuho Adjusts Price Target on IQVIA Holdings to $230 From $215, Maintains Outperform Rating - marketscreener.com
IQV Maintained by Mizuho -- Price Target Raised to $230 - GuruFocus
IQVIA stock steadies as data-driven health services underpin long-term growth - ad-hoc-news.de
Why is Larry Robbins Bullish on IQVIA Holdings (IQV) Amid Market Volatility - Kavout | AI
Analysts Are Neutral on Top Healthcare Stocks: IQVIA Holdings (IQV), Qiagen (QGEN) - The Globe and Mail
IQVIA Holdings Inc. stock outperforms competitors on strong trading day - MSN
IQV News | IQVIA HOLDINGS INC (NYSE:IQV) - ChartMill
IQVIA stock stays supported by data-driven healthcare demand - ad-hoc-news.de
IQVIA Holdings (IQV) Q1 2026 Earnings Call Transcript - Fortune
IQVIA (IQV) Just Drew A New Artisan Partners Bet On AI And Resilience - Yahoo Finance
symbol__ Stock Quote Price and Forecast - CNN
IQVIA Holdings stock stays supported by data-driven healthcare demand - ad-hoc-news.de
IQVIA to Announce Second-Quarter 2026 Results on July 28, 2026 - BioSpace
IQVIA to announce Q2FY26 results on July 28, 2026 - scanx.trade
RBC Capital Maintains IQVIA Holdings(IQV.US) With Buy Rating, Maintains Target Price $221 - Moomoo
IQVIA Holdings (IQV) Draws Undervalued Attention, Is The Recent Momentum Fully Priced In? - simplywall.st
IQVIA Holdings Inc. stock outperforms competitors despite losses on the day - MarketWatch
IQVIA sets July 28 call for second-quarter 2026 results - Stock Titan
Is IQVIA Holdings (IQV) Resilient to AI Concerns? - Yahoo Finance
(IQV) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
IQVIA Holdings Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
IQVIA stock holds its line as investors await a fresh catalyst. - AD HOC NEWS
Evercore ISI Adjusts Price Target on IQVIA Holdings Inc to $225 From $195 - Moomoo
Argus Adjusts Price Target on IQVIA Holdings to $235 From $215 - marketscreener.com
HSBC Adjusts Price Target on IQVIA Holdings Inc to $240 From $210 - Moomoo
IQVIA stock steadies on a thin catalyst day. - Ad-hoc-news.de
IQVIA Holdings, Inc. (IQV) Investor Outlook: Analyzing Growth Potential With A 9.39% Upside - DirectorsTalk Interviews
IQVIA stock holds focus on its data and services model. - Ad-hoc-news.de
IQVIA board authorizes additional $2 billion stock buyback - Investing.com
IQVIQVIA Holdings Inc Volatility & Greeks - Finviz
The IQVIA CORE – IQVIA Holdings leans on real-world data backbone - AD HOC NEWS
MidCap Value Fund I's IQVIA Holdings Inc(IQV) Holding History - GuruFocus
IQVIA Holdings Inc outlook and operations as a healthcare data leader - Ad-hoc-news.de
Here's Why Investors Should Hold IQV Stock in Their Portfolios Now - TradingView
IQVIA Holdings' Q2 2026 Earnings: What to Expect - Yahoo Finance
IQVIA Holdings (IQV) Is Up 11.1% After Raising Earnings Outlook And Highlighting AI Research Role - Sahm
IQVIA Holdings Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Hardman Johnston Large Cap Equity Holds Firm on IQVIA Holdings (IQV). Here’s Why - Yahoo Finance
IQVIA Holdings Inc (IQV) Stock Up 5.2% and Still Undervalued -- GF Score: 90/100 - GuruFocus
Why Is IQVIA (IQV) Stock Soaring Today - Yahoo Finance
IQVIA Holdings highlights its data-driven healthcare platform. Investors focus on long-term growth p - AD HOC NEWS
Baird Adjusts Price Target on IQVIA Holdings Inc to $249 From $230, Maintains Outperform Rating - marketscreener.com
Baird Maintains IQVIA Holdings(IQV.US) With Buy Rating, Cuts Target Price to $249 - Moomoo
The IQVIA MedTech Acceleratordata-driven support for smaller device makers - AD HOC NEWS
Are Wall Street analysts predicting IQVIA Holdings stock will climb or sink? - MSN
IQVIA Holdings Inc. stock rises Monday, still underperforms market - MarketWatch
Truist Financial Maintains IQVIA Holdings(IQV.US) With Buy Rating - Moomoo
IQVIA Holdings updates AI-powered analytics push, shares on NYSE radar - AD HOC NEWS
IQVIA Life Sciences Hub from IQVIA Holdingsunified data backbone for pharma teams - AD HOC NEWS
The Orchestrated Patient Recruitment from IQVIA Holdings Inc.data-driven outreach for tough trial - AD HOC NEWS
IQVIA Holdings Inc Actuals & Estimates (NYSE:IQV) - TradingView
아이큐비아 홀딩스 (IQV) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.85%
1.09%
자본화:
|
볼륨(24시간):